Category: hemp

Canbiola, Inc. (CANB) Announces “2017 Review – Update to Shareholders”

HICKSVILLE, NY / ACCESSWIRE / January 3, 2018 / Canbiola, Inc. (OTC PINK: CANB) is happy to provide this update to shareholders and review major events and accomplishments in 2017. Dear Shareholder, 2017 was a transition year as we transformed the company from a technology/software company to a company participating in the growing cannabis industry, with a focus on selling and developing products containing Cannabidiol (CBD) derived from industrial hemp. Here’s an overview of our proud accomplishments for 2017: Medical Advisory Board and Distributors: We added a number of medical professionals to our Advisory Board in addition to entering into distribution agreements with each. Read below our specific announcements on the five medical professionals added in 2017: Dr. Robert A. Kornfeld Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor Dr. John P. Salerno Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor Dr. Patrick M. Fratellone Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor Dr. Harry Benisatto joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor Canbiola, Inc. (CANB) Announces Addition of Smita Ohri M.D. as Medical Advisor Manufacturing: We can proudly announce today that in the last quarter of 2017 we established a manufacturing agreement with a 3rd party manufacturer in the U.S. whereby we will be able to directly manufacture at manufacturers cost and white-label others’ products with no up-front fees due from the company....

Read More

Hemp Oil and Arthritis

Getty For over three decades, natural products have been studied and tested as possible treatments for inflammation. This is a major breakthrough for people that suffer from inflammatory conditions, like arthritis and fibromyalgia. Hemp oil is one of the leading Ayurvedic-based methods for targeting inflammation. What Causes Inflammation? Sugar, saturated fats, trans fats, white flour, MSG and alcohol are the major food ingredients that promote inflammation. The North American diet is nutritionally unbalanced with an excess of linoleic over alpha-linolenic acid. Hempseed oil has an optical ratio for providing healthy human adipose tissue. Gamma-linolenic acid (GLA) is another component...

Read More

Hemp and Green Energy are Destined to Marry

Getty Everyone dreams of a green planet where energy is abundant and inexpensive. Hemp is a natural resource that has long been overlooked as one material that can put this plan into motion. While scientists struggle to find new ways to incorporate graphene into energy storage solutions, the waste from hemp plants is proving more justified as a sweeter alternative. Currently, home energy storage relies on lithium-ion or lead-acid batteries for later distribution. However, the toxic impact of lead and the difficulty in recycling lithium counteract the environmental purpose of green energy. These high capacity batteries are also slow...

Read More

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Discusses Therapeutic Benefits of Cannabis During Annual International League Against Epilepsy Meeting

Renowned Mexican Neurologist Presents on Effects of Real Scientific Hemp Oil-X™ (RSHO-X™) in Treating Children with Severe Epilepsy SAN DIEGO, July 27, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico participated in the LX Annual Meeting and National Congress of the Mexican Chapter of the International League Against Epilepsy, which took place in Tijuana, Mexico from July 26th to 29th. HempMeds® Mexico provided information about cannabinoid products for the treatment of neurodegenerative conditions, such as epilepsy, as well as the results obtained by Mexican doctors using the first cannabis based treatment approved in Mexico that is the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™). Mexican pediatric neurologist Dr. Saul Garza Morales presented information from a study involving 39 patients with Lennox-Gastaut syndrome, a severe form of pediatric epilepsy that typically develops before the age of four. Of those 39 patients, which took up to 5-7mg CBD/kg progressive doses of RSHO-X™ 5000MG, 84% experienced reduction in motor seizures; 53% reported better than a 75% reduction in seizures; and 17% reported a complete elimination of all seizures over a 4-month period, with zero reported side effects. “This was an incredible opportunity to meet with other doctors and discuss the latest research in the cannabinoid space,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It was wonderful to see presentations made regarding the Endogenous Cannabinoid System and view some of the emerging...

Read More
  • 1
  • 2